Remdesivir Completed Phase 3 Trials for Covid-19 ARDS / Coronavirus Disease 2019 (COVID‑19) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT04678739 | Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial |